Mohit Bansal

Q: What is Mohit Bansal's success rate?

Mohit Bansal currently has a success rate of 73.2100809014462.

Q: What is the average return of Mohit Bansal's calls?

Their stock ratings have generated an average return of 10.411076674514263.

Wells Fargo | Healthcare

Mohit Bansal is an analyst from Wells Fargo specializing in the Healthcare sector. Ranked #2274 out of 4627 analysts, they have issued 38 stock ratings with a success rate of 73.21% and an average return of 10.41%.

Mohit Bansal has a well-established track record, with 38 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 73.21% and an average return of 10.41%, underscoring their expertise and ability to identify winning opportunities for investors.

#2274

Out of 4627

Total Ratings

+73.21%

Success Rate

+10.41%

Average Return

Recent Ratings Analysis

BIIB

Buy

Apr 20, 2026

Target

$250.00

Current

$183.34

Performance

0.00%

Mohit Bansal rated BIIB as Overweight on Apr 20, 2026, setting a price target of 250. Shares have remained stable near 183.34, leaving the 250 target still in play.

MRK

Buy

Mar 12, 2026

Target

$150.00

Current

$117.13

Performance

1.05%

On Mar 12, 2026, MRK was given a Overweight rating by Mohit Bansal, with a target price of 150. The stock traded sideways with a 1.05% move, keeping the bullish thesis unresolved.

JAZZ

Buy

Feb 25, 2026

Target

$250.00

Current

$202.56

Performance

2.91%

JAZZ received a Overweight rating from Mohit Bansal on Feb 25, 2026, aiming for 250. Price action was muted, as shares hovered around 202.56 despite the bullish outlook.

HALO

Hold

Feb 19, 2026

Target

$75.00

Current

$69.57

Performance

-3.43%

On Feb 19, 2026, Mohit Bansal published a Equal-Weight outlook on HALO, with a target of 75. Sideways action left the Hold view intact, with no major move since 69.57.

AMGN

Hold

Feb 19, 2026

Target

$375.00

Current

$350.16

Performance

-6.75%

Mohit Bansal on Feb 19, 2026 assigned AMGN a Equal-Weight rating, with a price target of 375. The call successfully avoided chasing as shares lost 6.75%.

BMRN

Buy

Feb 18, 2026

Target

$75.00

Current

$54.88

Performance

-11.24%

On Feb 18, 2026, Mohit Bansal reaffirmed BMRN with a Overweight rating, targeting 75. Shares slid 11.24% despite the recommendation, highlighting downside risks.

NBIX

Buy

Feb 13, 2026

Target

$180.00

Current

$131.59

Performance

6.02%

NBIX was rated Overweight by Mohit Bansal on Feb 13, 2026, with a price objective of 180. A bullish response from the market helped close the gap of 48.41 to the target.

GILD

Buy

Feb 11, 2026

Target

$165.00

Current

$135.87

Performance

-12.79%

On Feb 11, 2026, Mohit Bansal initiated coverage on GILD with a Overweight rating and target of 165. The Buy call has yet to be validated as shares remain 29.13 away from the target.

BMY

Hold

Feb 06, 2026

Target

$60.00

Current

$59.13

Performance

-4.61%

Mohit Bansal issued a Equal-Weight recommendation for BMY on Feb 06, 2026, price target set at 60. The rating was appropriate for a consolidating market trading near 59.13.

LLY

Buy

Feb 05, 2026

Target

$1280.00

Current

$919.90

Performance

-9.89%

On Feb 05, 2026, LLY was evaluated by Mohit Bansal, who gave a Overweight rating and target of 1280. Investors saw limited payoff as shares fell short of the 1280 target.

REGN

Hold

Feb 02, 2026

Target

$800.00

Current

$749.41

Performance

-0.74%

Mohit Bansal rated REGN as Equal-Weight on Feb 02, 2026, setting a price target of 800. The Hold stance appears justified, as shares hovered around 749.41 with a -0.74% move.

IRWD

Hold

Jan 05, 2026

Target

$5.00

Current

$4.42

Performance

-3.70%

On Jan 05, 2026, IRWD was given a Equal-Weight rating by Mohit Bansal, with a target price of 5. Market indecision, reflected in sideways trading near 4.42, supported the cautious call.

MIST

Buy

Dec 16, 2025

Target

$8.00

Current

$2.04

Performance

-7.27%

MIST received a Overweight rating from Mohit Bansal on Dec 16, 2025, aiming for 8. The rating hasn’t played out as hoped, with the stock trading 7.27% below expectations.

VRTX

Buy

Dec 10, 2025

Target

$515.00

Current

$439.18

Performance

-1.23%

On Dec 10, 2025, Mohit Bansal published a Overweight outlook on VRTX, with a target of 515. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 439.18.

MLYS

Buy

Nov 11, 2025

Target

$55.00

Current

$30.07

Performance

-36.17%

Mohit Bansal on Nov 11, 2025 assigned MLYS a Overweight rating, with a price target of 55. The call has struggled to gain traction, with shares losing 36.17%.

ABBV

Buy

Sep 12, 2025

Target

$260.00

Current

$203.71

Performance

-6.70%

On Sep 12, 2025, Mohit Bansal reaffirmed ABBV with a Overweight rating, targeting 260. Shares slid 6.70% despite the recommendation, highlighting downside risks.

TVTX

Buy

Sep 11, 2025

Target

$35.00

Current

$40.29

Performance

61.16%

TVTX was rated Overweight by Mohit Bansal on Sep 11, 2025, with a price objective of 35. A bullish response from the market helped close the gap of -5.29 to the target.

BNTX

Buy

Aug 05, 2025

Target

$150.00

Current

$105.19

Performance

-5.29%

On Aug 05, 2025, Mohit Bansal initiated coverage on BNTX with a Overweight rating and target of 150. The Buy call has yet to be validated as shares remain 44.81 away from the target.

SMMT

Buy

Dec 11, 2024

Target

$30.00

Current

$25.12

Performance

33.83%

Mohit Bansal issued a Overweight recommendation for SMMT on Dec 11, 2024, price target set at 30. Investors following the Buy call captured upside momentum, with shares now at 25.12.

VERA

Buy

Nov 21, 2024

Target

$70.00

Current

$41.61

Performance

-11.52%

On Nov 21, 2024, VERA was evaluated by Mohit Bansal, who gave a Overweight rating and target of 70. Investors saw limited payoff as shares fell short of the 70 target.

PFE

Hold

Jul 31, 2024

Target

$30.00

Current

$27.52

Performance

-9.89%

Mohit Bansal rated PFE as Equal-Weight on Jul 31, 2024, setting a price target of 30. The cautious Hold call aligned with subsequent weakness, as shares slipped 9.89%.

Frequency Asked Questions

Who is Mohit Bansal?

Mohit Bansal is an analyst from Wells Fargo specializing in the Healthcare sector.

What is Mohit Bansal's success rate?

Mohit Bansal currently has a success rate of +73.21%.

How many ratings has Mohit Bansal issued?

Mohit Bansal has issued 38 stock ratings so far.

What is the average return of Mohit Bansal's calls?

Their stock ratings have generated an average return of +10.41%.

What is Mohit Bansal's ranking?

Mohit Bansal is ranked #2274 out of 4627 analysts.

What types of ratings does Mohit Bansal give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Mohit Bansal?

You can follow Mohit Bansal by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Mohit Bansal?

Their latest rating was a Buy on BIIB issued on 2026-04-20.